The above observations and evidence have gained momentum and thrown light on myo-inositol as a potential insulin-sensitizing agent to be utilized as a treatment option in PCOS patients to restore metabolic function and consequently ovulation. The gene discussed is INS; the disease is polycystic ovary syndrome.